M Cavassini
Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients: the Swiss HIV Cohort Study
Young J, Bucher H, Battegay M, Hirschel B, Vernazza P, Bernasconi E, Cavassini M, Fux C, Rickenbach M, Böni J, Yerly S, Opravil M, Günthard H, Scherrer A, for the Swiss HIV Cohort Study. Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients: the Swiss HIV Cohort Study. HIV Med 2010
Oct 18, 2010Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients: the Swiss HIV Cohort Study
Oct 18, 2010HIV Med 2010
Young J, Bucher Hc, Battegay M, Hirschel B, Vernazza Pietro, Bernasconi E, Cavassini M, Fux Ca, Rickenbach M, Böni J, Yerly S, Opravil M, Günthard Hf, Scherrer Au, for the Swiss HIV Cohort Study
Trends over time of virological and immunological characteristics in the Swiss HIV Cohort Study(*)
Ledergerber B, Weber R, Rickenbach M, Furrer H, Hirschel B, Vernazza P, Bernasconi E, Battegay M, Cavassini M, and the Swiss HIV Cohort Study (SHCS). Trends over time of virological and immunological characteristics in the Swiss HIV Cohort Study(*). HIV Med 2010
Oct 18, 2010Trends over time of virological and immunological characteristics in the Swiss HIV Cohort Study(*)
Oct 18, 2010HIV Med 2010
Ledergerber B, Weber R, Rickenbach M, Furrer H, Hirschel B, Vernazza Pietro, Bernasconi E, Battegay M, Cavassini M, and the Swiss HIV Cohort Study (SHCS)
How reliable is an undetectable viral load?
Combescure C, Hirschel B, Vernazza P, Bernasconi E, Battegay M, Rauch A, Furrer H, Cavassini M, Ledergerber B, Vallier N, Swiss HIV Cohort Study. How reliable is an undetectable viral load?. HIV medicine 2009; 10:470-6.
Sep 1, 2009How reliable is an undetectable viral load?
Sep 1, 2009HIV medicine 2009; 10:470-6
Combescure Christophe, Hirschel B, Vernazza Pietro, Bernasconi E, Battegay M, Rauch A, Furrer H, Cavassini M, Ledergerber B, Vallier N, Swiss HIV Cohort Study
Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study
Weber R, Ledergerber B, Schmid P, Bernasconi E, Cavassini M, Hirschel B, Elzi L, Furrer H, Rickenbach M, Huber M, Swiss HIV Cohort Study. Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study. HIV medicine 2009; 10:407-16.
Aug 1, 2009Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study
Aug 1, 2009HIV medicine 2009; 10:407-16
Weber R, Ledergerber B, Schmid Patrick, Bernasconi E, Cavassini M, Hirschel B, Elzi L, Furrer H, Rickenbach M, Huber M, Swiss HIV Cohort Study
Liver enzyme elevation after lamivudine withdrawal in HIV-hepatitis B virus co-infected patients: the Swiss HIV Cohort Study
Bellini C, Cavassini M, Telenti A, Bernasconi E, Vernazza P, Weber R, Kaiser L, Fehr J, Evison J, Chave J, Keiser O, Swiss HIV Cohort Study. Liver enzyme elevation after lamivudine withdrawal in HIV-hepatitis B virus co-infected patients: the Swiss HIV Cohort Study. HIV medicine 2009; 10:12-8.
Jan 1, 2009Liver enzyme elevation after lamivudine withdrawal in HIV-hepatitis B virus co-infected patients: the Swiss HIV Cohort Study
Jan 1, 2009HIV medicine 2009; 10:12-8
Bellini C, Cavassini M, Telenti A, Bernasconi E, Vernazza Pietro, Weber R, Kaiser L, Fehr J, Evison Jm, Chave J-P, Keiser O, Swiss HIV Cohort Study
Androgen and gonadotropin patterns differ in HIV-1-infected men who develop lipoatrophy during antiretroviral therapy: a case-control study
Wunder D, Furrer H, Mueller B, Bernasconi E, Schmid P, Elzi L, Cavassini M, Hirschel B, Mueller N, Bersinger N, Fux C, Swiss HIV Cohort Study. Androgen and gonadotropin patterns differ in HIV-1-infected men who develop lipoatrophy during antiretroviral therapy: a case-control study. HIV medicine 2008; 9:427-32.
Jul 1, 2008Androgen and gonadotropin patterns differ in HIV-1-infected men who develop lipoatrophy during antiretroviral therapy: a case-control study
Jul 1, 2008HIV medicine 2008; 9:427-32
Wunder D M, Furrer H, Mueller B, Bernasconi E, Schmid Patrick, Elzi L, Cavassini M, Hirschel B, Mueller N J, Bersinger N A, Fux C A, Swiss HIV Cohort Study
Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study
Wolbers M, Battegay M, Hirschel B, Bernasconi E, Schmid P, Weber R, Cavassini M, Rickenbach M, Furrer H, Bucher H, Swiss HIV Cohort Study. Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study. HIV medicine 2008; 9:397-405.
Jul 1, 2008Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study
Jul 1, 2008HIV medicine 2008; 9:397-405
Wolbers M, Battegay M, Hirschel B, Bernasconi E, Schmid Patrick, Weber R, Cavassini M, Rickenbach M, Furrer H, Bucher H C, Swiss HIV Cohort Study
Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study
Glass T, Bucher H, Battegay M, Hirschel B, Cavassini M, Bernasconi E, Furrer H, Rickenbach M, Vernazza P, Weber R, Wolbers M, Ungsedhapand C, Swiss HIV Cohort Study. Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study. HIV medicine 2006; 7:404-10.
Sep 1, 2006Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study
Sep 1, 2006HIV medicine 2006; 7:404-10
Glass T R, Bucher H C, Battegay M, Hirschel B, Cavassini M, Bernasconi E, Furrer H, Rickenbach M, Vernazza Pietro, Weber R, Wolbers M, Ungsedhapand C, Swiss HIV Cohort Study
Discontinuation of maintenance therapy against toxoplasma encephalitis in AIDS patients with sustained response to anti-retroviral therapy
Bertschy S, Furrer H, Christen A, Chave J, Flepp M, Schmid P, Schiffer V, Bernasconi E, Cavassini M, Opravil M, Swiss HIV Cohort Study. Discontinuation of maintenance therapy against toxoplasma encephalitis in AIDS patients with sustained response to anti-retroviral therapy. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2006; 12:666-71.
Jul 1, 2006Discontinuation of maintenance therapy against toxoplasma encephalitis in AIDS patients with sustained response to anti-retroviral therapy
Jul 1, 2006Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2006; 12:666-71
Bertschy S, Furrer H, Christen A, Chave J-P, Flepp M, Schmid Patrick, Schiffer V, Bernasconi E, Cavassini M, Opravil M, Swiss HIV Cohort Study
Failures of 1 week on, 1 week off antiretroviral therapies in a randomized trial
Ananworanich J, Ebnöther C, Fagard C, Genné D, Khanna N, Perrin L, Phanupak P, Ubolyam S, Vernazza P, Yerly S, Cavassini M, Bernasconi E, Nüesch R, Le Braz M, Chetchotisakd P, Vibhagool A, Wicharuk S, Ruxrungtham K, Furrer H, Cooper D, Hirschel B, Swiss HIV Cohort Study. Failures of 1 week on, 1 week off antiretroviral therapies in a randomized trial. AIDS (London, England) 2003; 17:F33-7.
Oct 17, 2003Failures of 1 week on, 1 week off antiretroviral therapies in a randomized trial
Oct 17, 2003AIDS (London, England) 2003; 17:F33-7
Ananworanich Jintanat, Ebnöther C, Fagard C, Genné D, Khanna N, Perrin L, Phanupak P, Ubolyam S, Vernazza Pietro, Yerly S, Cavassini M, Bernasconi E, Nüesch Reto, Le Braz Michelle, Chetchotisakd Ploechan, Vibhagool Asda, Wicharuk Saijai, Ruxrungtham Kiat, Furrer Hansjakob, Cooper David, Hirschel Bernard, Swiss HIV Cohort Study